Rossy Foundation awards $10 million to Dana-Farber Cancer Institute

With the aim of advancing treatments for liposarcoma, a rare, underfunded, and understudied disease, the five-year initiative will support collaborative research across departments at Dana-Farber and partner organizations….

Related Articles

Responses

Your email address will not be published. Required fields are marked *